 |
GXO |  |
| ISIN | GB0009252882 |
| Security | GXO |
| Exchange | ICE Europe |
| Type | Future |
Futures
| Exp. date | Last | Open Interest | |
|---|---|---|---|
| 6/22 | |||
| 7/22 | |||
| 8/22 | |||
| 9/22 | |||
| 10/22 | |||
| 11/22 | |||
| 12/22 | |||
| 1/23 | |||
| 2/23 | |||
| 3/23 | |||
| 4/23 | |||
| 5/23 | |||
| 6/23 | |||
| 7/23 | |||
| 8/23 | |||
| 9/23 | |||
| 10/23 | |||
| 11/23 | |||
| 12/23 | |||
| 1/24 | |||
| 2/24 | |||
| 3/24 | |||
| 4/24 | |||
| 5/24 | |||
| 6/24 | |||
| 7/24 | |||
| 8/24 | |||
| 9/24 | |||
| 10/24 | |||
| 11/24 | |||
| 12/24 | |||
| 1/25 | |||
| 2/25 | |||
| 3/25 | |||
| 4/25 | |||
| 5/25 | |||
| 6/25 | |||
| 7/25 | |||
| 8/25 | |||
| 9/25 | |||
| 10/25 | |||
| 11/25 | |||
| 12/25 | |||
| 1/26 | |||
| 2/26 | |||
| 3/26 | |||
| 4/26 | |||
| 5/26 | |||
| 6/26 | |||
| 7/26 | |||
| 8/26 | |||
| 9/26 | |||
| 10/26 | |||
| 11/26 | |||
| 12/26 | |||
| 1/27 | |||
| 2/27 | |||
| 3/27 | |||
| 4/27 |
News
- GSK's turnover at £9.78B in Q1, up 32% YoY
04/27/2022 / 08:10 - TeleTrader - EMA begins reviewing Sanofi-GSK COVID-19 vaccine
03/30/2022 / 17:37 - TeleTrader - US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
03/25/2022 / 21:04 - GlobeNewswire - Radius Health Announces Leadership Appointments
03/16/2022 / 13:30 - GlobeNewswire - GXO Deploys a Fleet of Autonomous Robots in the U.K. and the Netherlands
03/16/2022 / 10:00 - GlobeNewswire
Real-time